FDA | Press Releases
Follow
FDA Begins Real-Time Reporting of Adverse Event Data
The U.S. Food and Drug Administration (FDA) today began publishing adverse event data on a daily basis, giving the public faster access to information on serious medication errors and product quality complaints for prescription drugs and therapeutic biologics.
